Stress Therapeutics, Inc.
Publicly observedSan Diego, United States
Seen in a public record (e.g. a government grant database); not otherwise verified.
Details and provenance
| Item | Value | Source | Status |
|---|---|---|---|
| Country | US | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| City / locality | San Diego | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| Name | Stress Therapeutics, Inc. | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| UEI (U.S. federal entity ID) | VLU8DHDM9JZ3 | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
Recorded events
- Grant1 Jun 2025Publicly observed
NIH SBIR/STTR award: Lead Optimization of a Therapeutic Candidate for Alzheimer’s Disease
USD 349,605.00 · National Institute on Aging · Source: NIH RePORTER (opens in a new tab)
- Grant15 May 2025Publicly observed
NIH SBIR/STTR award: Investigational New Drug (IND)-enabling Study for a New Therapeutic for Alcohol Use Disorder (AUD)
USD 995,447.00 · National Institute on Alcohol Abuse and Alcoholism · Source: NIH RePORTER (opens in a new tab)
- Grant15 May 2025Publicly observed
NIH SBIR/STTR award: Investigational New Drug (IND)-enabling Study for a New Therapeutic for Alcohol Use Disorder (AUD)
USD 999,393.00 · National Institute on Alcohol Abuse and Alcoholism · Source: NIH RePORTER (opens in a new tab)
- Grant1 Sept 2019Publicly observed
NIH SBIR/STTR award: Novel therapeutic for HPA hyperactivity
USD 716,742.00 · National Institute on Alcohol Abuse and Alcoholism · Source: NIH RePORTER (opens in a new tab)
Information only — not investment advice or an endorsement. Is this your company? Submit or update its details or request a correction.